Darabi A - Search Results

1

Establishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluation.

Sandén E, Dyberg C, Krona C, Gallo-Oller G, Olsen TK, Enríquez Pérez J, Wickström M, Estekizadeh A, Kool M, Visse E, Ekström TJ, Siesjö P, Johnsen JI, Darabi A. Sandén E, et al. Among authors: darabi a. Sci Rep. 2017 Apr 18;7:46366. doi: 10.1038/srep46366. Sci Rep. 2017. PMID: 28417956 Free PMC article.

2

Characterization of membrane-associated actin in boar spermatozoa.

Peterson RN, Bozzola JJ, Hunt WP, Darabi A. Peterson RN, et al. Among authors: darabi a. J Exp Zool. 1990 Feb;253(2):202-14. doi: 10.1002/jez.1402530210. J Exp Zool. 1990. PMID: 2313248

3

Activation of purified allogeneic CD4(+) T cells by rat bone marrow-derived dendritic cells induces concurrent secretion of IFN-gamma, IL-4, and IL-10.

Janelidze S, Enell K, Visse E, Darabi A, Salford LG, Siesjö P. Janelidze S, et al. Among authors: darabi a. Immunol Lett. 2005 Nov 15;101(2):193-201. doi: 10.1016/j.imlet.2005.05.012. Immunol Lett. 2005. PMID: 16002150

4

Synergism between GM-CSF and IFNgamma: enhanced immunotherapy in mice with glioma.

Smith KE, Janelidze S, Visse E, Badn W, Salford L, Siesjö P, Darabi A. Smith KE, et al. Among authors: darabi a. Int J Cancer. 2007 Jan 1;120(1):75-80. doi: 10.1002/ijc.22286. Int J Cancer. 2007. PMID: 17044023

5

Inhibition of inducible nitric oxide synthase enhances anti-tumour immune responses in rats immunized with IFN-gamma-secreting glioma cells.

Badn W, Hegardt P, Fellert MA, Darabi A, Esbjörnsson M, Smith KE, Janelidze S, Salford LG, Visse E, Siesjö P. Badn W, et al. Among authors: darabi a. Scand J Immunol. 2007 Mar;65(3):289-97. doi: 10.1111/j.1365-3083.2007.01901.x. Scand J Immunol. 2007. PMID: 17309784 Free article.

6

Postimmunization with IFN-gamma-secreting glioma cells combined with the inducible nitric oxide synthase inhibitor mercaptoethylguanidine prolongs survival of rats with intracerebral tumors.

Badn W, Visse E, Darabi A, Smith KE, Salford LG, Siesjö P. Badn W, et al. Among authors: darabi a. J Immunol. 2007 Sep 15;179(6):4231-8. doi: 10.4049/jimmunol.179.6.4231. J Immunol. 2007. PMID: 17785863

7

Cure of established GL261 mouse gliomas after combined immunotherapy with GM-CSF and IFNgamma is mediated by both CD8+ and CD4+ T-cells.

Smith KE, Fritzell S, Badn W, Eberstål S, Janelidze S, Visse E, Darabi A, Siesjö P. Smith KE, et al. Among authors: darabi a. Int J Cancer. 2009 Feb 1;124(3):630-7. doi: 10.1002/ijc.23986. Int J Cancer. 2009. PMID: 18972433

8

CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas.

Bexell D, Gunnarsson S, Siesjö P, Bengzon J, Darabi A. Bexell D, et al. Among authors: darabi a. Int J Cancer. 2009 Jul 1;125(1):15-22. doi: 10.1002/ijc.24306. Int J Cancer. 2009. PMID: 19291792

9

Immunizations with IFNgamma secreting tumor cells can eliminate fully established and invasive rat gliomas.

Janelidze S, Bexell D, Badn W, Darabi A, Smith KE, Fritzell S, Gunnarsson S, Milos P, Bengzon J, Salford LG, Siesjö P, Visse E. Janelidze S, et al. Among authors: darabi a. J Immunother. 2009 Jul-Aug;32(6):593-601. doi: 10.1097/CJI.0b013e3181a95148. J Immunother. 2009. PMID: 19483650

10

Intratumoral IL-7 delivery by mesenchymal stromal cells potentiates IFNgamma-transduced tumor cell immunotherapy of experimental glioma.

Gunnarsson S, Bexell D, Svensson A, Siesjö P, Darabi A, Bengzon J. Gunnarsson S, et al. Among authors: darabi a. J Neuroimmunol. 2010 Jan 25;218(1-2):140-4. doi: 10.1016/j.jneuroim.2009.10.017. Epub 2009 Nov 14. J Neuroimmunol. 2010. PMID: 19914721

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

112 results

Search Page

Filters